Michael E Friduss, MD
Otolaryngology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 3 carriers
- Office
- 1
Offices
1 location · UCSF Medical Group Business Services · 1,533 clinicians in this group
Plans that list them
11 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Friduss’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G53564 · Current
Licensed to practise in California · since 1984 · expires 2028-01-31 · University of Illinois College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$19,181
Medicare paid this office $19,181 for 116 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 28 | $2,942 | $82 |
| Diagnostic exam of voice box using a flexible endoscope | 21 | $2,785 | $121 |
| Return visit (30+ min) | 16 | $2,511 | $120 |
| Comprehensive hearing and speech recognition test | 64 | $1,871 | $28 |
| New patient visit (30+ min) | 17 | $1,801 | $106 |
See all 10 services
| Short return visit (20+ min) | 28 | $2,942 | $82 |
| Diagnostic exam of voice box using a flexible endoscope | 21 | $2,785 | $121 |
| Return visit (30+ min) | 16 | $2,511 | $120 |
| Comprehensive hearing and speech recognition test | 64 | $1,871 | $28 |
| New patient visit (30+ min) | 17 | $1,801 | $106 |
| Short return visit | 23 | $1,415 | $52 |
| Removal of impacted ear wax | 23 | $964 | $36 |
| Test to assess middle ear function | 53 | $759 | $14 |
| Exam of ear using a microscope | 14 | $393 | $28 |
| Test for eardrum and muscle function | 11 | $167 | $15 |
Who their Medicare patients are
116 Original Medicare patients in 2024. Average age 73 · Women 41% · Also on Medicaid 16% · Health risk score 1.42. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 64% · Diabetes 28% · Chronic kidney disease 23% · Coronary heart disease 22% · Cancer 22% · Depression 19% · Heart failure 12% · Atrial fibrillation 12%.
The office billed $110,762, Medicare allowed $25,853 and paid $19,181; for 319 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 116 | 319 | 73 | 1.42 | $110,762 | $19,181 |
| 2023 | 99 | 282 | 71 | 1.30 | $133,293 | $22,792 |
| 2022 | 97 | 282 | 72 | 1.04 | $127,934 | $20,585 |
| 2021 | 76 | 123 | 75 | 0.94 | $63,400 | $8,509 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Diagnostic exam of voice box using a flexible endoscope | 40 | $5,204 | $124 |
| New patient visit (30+ min) | 33 | $3,401 | $103 |
| Short return visit (20+ min) | 30 | $3,165 | $79 |
| Short return visit | 16 | $1,006 | $53 |
| Exam of ear using a microscope | 27 | $976 | $30 |
| Removal of impacted ear wax | 21 | $868 | $36 |
| Comprehensive hearing and speech recognition test | 26 | $766 | $29 |
| Test to assess middle ear function | 23 | $350 | $15 |
2022: 8 services
| New patient visit (30+ min) | 32 | $3,086 | $96 |
| Diagnostic exam of voice box using a flexible endoscope | 23 | $2,884 | $111 |
| Short return visit (20+ min) | 20 | $2,018 | $84 |
| Short return visit | 16 | $1,054 | $50 |
| Comprehensive hearing and speech recognition test | 37 | $988 | $27 |
| Exam of ear using a microscope | 24 | $894 | $28 |
| Removal of impacted ear wax | 21 | $891 | $37 |
| Test to assess middle ear function | 29 | $421 | $15 |
2021: 5 services
| New patient visit (30+ min) | 30 | $2,308 | $77 |
| New patient visit (45+ min) | 13 | $1,624 | $125 |
| New patient visit (15+ min) | 16 | $735 | $46 |
| Removal of impacted ear wax | 13 | $364 | $28 |
| Exam of ear using a microscope | 11 | $137 | $12 |
Drugs they prescribed that Part D paid
$1,684
Pharmacies billed $1,684 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
69 generic and 0 brand-name prescriptions · $1,684 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 20 | $772 | $39 |
Year by year
| 2024 | 69 | 27 | None | 0% | $1,684 |
| 2023 | 88 | 33 | None | None | $2,428 |
| 2022 | 59 | 27 | 0% (0) | None | $3,300 |
| 2021 | 45 | 23 | None | None | $1,333 |
| 2020 | 156 | 69 | 9% (14) | 7% | $3,185 |
| 2019 | 121 | 65 | 20% (24) | None | $1,963 |
| 2018 | 168 | 83 | 7% (12) | 8% | $4,468 |
| 2017 | 179 | 92 | 11% (19) | None | $10,719 |
| 2016 | 239 | 104 | 14% (33) | None | $7,909 |
| 2015 | 244 | 121 | 16% (39) | 5% | $10,585 |
| 2014 | 207 | 97 | 20% (42) | None | $6,678 |
| 2013 | 258 | 109 | 14% (37) | 8% | $8,076 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Fluticasone Propionate | 23 | $382 | $17 |
2022: 1 drug
| Fluticasone Propionate | 11 | $217 | $20 |
2020: 5 drugs
| Fluticasone Propionate | 26 | $538 | $21 |
| Levothyroxine | 15 | $407 | $27 |
| Prednisone | 14 | $167 | $12 |
| Hydrocodone-Acetaminophen | 13 | $102 | $8 |
| Ondansetron | 12 | $72 | $6 |
2019: 4 drugs
| Fluticasone Propionate | 18 | $404 | $22 |
| Hydrocodone-Acetaminophen | 20 | $176 | $9 |
| Prednisone | 13 | $149 | $11 |
| Ondansetron | 20 | $114 | $6 |
2018: 3 drugs
| Fluticasone Propionate | 27 | $561 | $21 |
| Prednisone | 17 | $205 | $12 |
| Hydrocodone-Acetaminophen | 11 | $83 | $8 |
2017: 6 drugs
| Ofloxacin | 15 | $5,595 | $373 |
| Fluticasone Propionate | 37 | $685 | $19 |
| Azelastine | 15 | $367 | $24 |
| Omeprazole | 11 | $264 | $24 |
| Ondansetron Odt | 16 | $211 | $13 |
| Hydrocodone-Acetaminophen | 12 | $207 | $17 |
2016: 6 drugs
| Fluticasone Propionate | 50 | $995 | $20 |
| Omeprazole | 22 | $702 | $32 |
| Acetaminophen-Codeine | 29 | $413 | $14 |
| Ipratropium | 16 | $341 | $21 |
| Ondansetron Odt | 22 | $197 | $9 |
| Prednisone | 12 | $159 | $13 |
2015: 6 drugs
| Fluticasone Propionate | 38 | $1,086 | $29 |
| Azelastine | 11 | $1,058 | $96 |
| Ofloxacin | 19 | $667 | $35 |
| Omeprazole | 16 | $570 | $36 |
| Acetaminophen-Codeine | 34 | $485 | $14 |
| Prednisone | 14 | $175 | $13 |
2014: 5 drugs
| Fluticasone Propionate | 32 | $1,069 | $33 |
| Ofloxacin | 17 | $664 | $39 |
| Hydrocodone-Acetaminophen | 38 | $564 | $15 |
| Ranitidine | 13 | $149 | $11 |
| Prednisone | 12 | $102 | $8 |
2013: 7 drugs
| Fluticasone Propionate | 45 | $1,422 | $32 |
| Omeprazole | 25 | $826 | $33 |
| Hydrocodone-Acetaminophen | 32 | $551 | $17 |
| Ofloxacin | 15 | $504 | $34 |
| Levothyroxine | 13 | $328 | $25 |
| Azithromycin | 11 | $307 | $28 |
| Ranitidine | 12 | $156 | $13 |
Money from drug and device companies
$23 in 2025
| 2025 | 1 | 1 | None | $23 |
| 2023 | 1 | 2 | None | $35 |
| 2021 | 1 | 1 | None | $39 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Tula | $23 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2025-09-18 | Tula | $23 |
See earlier years (2023, 2021)
2023: $35
| Smith+Nephew | Halo | $35 | 2 payments
|
2021: $39
| Medtronic | Pteye | $39 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265519193
- Licence
- CA G53564California G53564: Current · expires 2028-01-31
- Trained
- University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb), 1983
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G535640
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-31
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.